Chengdu Kanghua Stock Hits Day Low Amid Price Pressure, Closing at CNY 45.65

Chengdu Kanghua Biological Products Co., Ltd. experienced a significant decline today, with the stock dropping by 6.58% and reaching an intraday low of CNY 45.65. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past week, Chengdu Kanghua has seen a decrease of 4.11%, while its monthly performance reflects a slight decline of 0.78%. However, the company has faced more substantial challenges over the past year, with a notable drop of 36.51%, significantly underperforming the China Shanghai Composite, which gained 7.03% in the same timeframe. Despite these setbacks, the company reported a net profit of CNY 60.81 million for the first half of the year, marking a remarkable growth of 188.9%. Operating cash flow reached its highest at CNY 877.9 million, and raw material costs decreased by 8.7% year-over-year. With a market capitalization of CNY 5,972 million, Chengdu Kanghua maintains a return on equity of 6.39% and a price-to-book ratio of 1.68, indicating a fair valuation amidst its current challenges.